GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rennova Health Inc (OTCPK:RNVA) » Definitions » Operating Margin %

RNVA (Rennova Health) Operating Margin % : -22.95% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Rennova Health Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Rennova Health's Operating Income for the three months ended in Dec. 2023 was $-0.88 Mil. Rennova Health's Revenue for the three months ended in Dec. 2023 was $3.84 Mil. Therefore, Rennova Health's Operating Margin % for the quarter that ended in Dec. 2023 was -22.95%.

The historical rank and industry rank for Rennova Health's Operating Margin % or its related term are showing as below:


RNVA's Operating Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -4.175
* Ranked among companies with meaningful Operating Margin % only.

Rennova Health's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Rennova Health's Operating Income for the three months ended in Dec. 2023 was $-0.88 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $1.37 Mil.


Rennova Health Operating Margin % Historical Data

The historical data trend for Rennova Health's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rennova Health Operating Margin % Chart

Rennova Health Annual Data
Trend Mar14 Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -98.10 -235.35 -317.00 -10.89 7.31

Rennova Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.43 15.30 32.82 -16.99 -22.95

Competitive Comparison of Rennova Health's Operating Margin %

For the Diagnostics & Research subindustry, Rennova Health's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rennova Health's Operating Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rennova Health's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Rennova Health's Operating Margin % falls into.


;
;

Rennova Health Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Rennova Health's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=1.366 / 18.686
=7.31 %

Rennova Health's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-0.882 / 3.843
=-22.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rennova Health  (OTCPK:RNVA) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Rennova Health Operating Margin % Related Terms

Thank you for viewing the detailed overview of Rennova Health's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rennova Health Business Description

Traded in Other Exchanges
N/A
Address
477 S. Rosemary Avenue, Suite 800, West Palm Beach, FL, USA, 33401
Rennova Health Inc is a vertically integrated provider of healthcare-related products and services. The company operates through a single business segment namely the Hospital operations segment reflects the purchase of the hospital assets. Geographically, the activities are carried out throughout the region of the US.
Executives
Jonathan Immordino officer: Chief Financial Officer 3340, POSEIDON WAY, INDIALANTIC FL 32903
Marlene Mclennan officer: Chief Financial Officer 400 SOUTH AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401
Gary L Blum director 3278 WILSHIRE BOULEVARD, SUITE 603, LOS ANGELES, CALIFORNIA CA 90010
John Beach director 400 S. AUSTRALIAN AVENUE,, SUITE 800,, WEST PALM BEACH, FL 33401
Kamran Ajami director 3920 NW 43RD ST., COCONUT CREEK FL 33073
Trevor Langley director 1000 N. GREEN VALLEY PARKWAY, #440-420, HENDERSON NV 89074
Michael H Pollack officer: Interim CFO 114 WEST 47TH STREET, 19TH FLOOR, NEW YORK NY 10036
Sharon Lynne Hollis 10 percent owner 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Robert P Lee director 400 S. AUSTRALIAN AVE., #800, WEST PALM BEACH FL 33134
Aella, Ltd. 10 percent owner SUITE 104A, SAFFREY SQUARE, BANK LANE, PO BOX N-9306, NASSAU C5 000000
Epizon Ltd. 10 percent owner SUITE 104A, SAFFREY SQUARE, BANK LANE, PO BOX N-9306, NASSAU C5 000000
Michael Louis Goldberg director 2008 BAYVIEW DRIVE, FORT LAUDERDALE FL 33305
Benjamin Frank director 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Jason Adams officer: Chief Financial Officer 4700 SANTA DEL RAE AVENUE, FT MYERS FL 33901
George Lundberg officer: Editor in Chief and CMO 44 MONTGOMERY STREET, SUITE 800, SAN FRANCISCO CA 94104